Original Research
Sunday, October 13, 2024
12:45 PM–02:15 PM
Abstract
Introduction:
Medications for opioid use disorder (MOUD) are the standard of care for opioid use disorder (OUD) due to demonstrated reductions in both morbidity and mortality, however,medications are
Research Question or Hypothesis: How has the implementation of a MOUD consult service affected MOUD utilization, safety, and care coordination ?
Study Design: Retrospective Cohort
Methods:
Results: Out of 1456 encounters, 222 (15.2%) involved MAR consultation, and 1234 (84.8%) did not. MOUD was given in 81.5% of consult encounters compared to 14.9% in non-consult encounters (p <0.001). Consulted encounters were more likely to receive additional withdrawal medications (73.5% vs 31.5%, p <0.001) and were less likely to return to the hospital within 30 days of discharge (21.5% vs 31.5%, p=0.031).
Conclusion: Involvement of a pharmacist-integrated OUD consult service was associated with greater use of MOUD and withdrawal management medications, and reduced 30-day readmissions.
Presenting Author
Paul Stranges PharmDUniversity of Illinois at Chicago College of Pharmacy
Authors
Alexander Infante PharmD, BCPS
University of Illinois at Chicago College of Pharmacy
Jennie Jarrett PharmD, MMedEd, PhD, FCCP
University of Illinois at Chicago
Eden Keller PharmD
University of Illinois at Chicago College of Pharmacy
Erin Ryan PharmD
University of Illinois Chicago